Earnings Report /
Sri Lanka

Hemas Holdings: 4Q FY21 - Poised to deliver in FY22E; Atlas recovery will be key

  • MORI manufacturing to be a tailwind for Healthcare from FY22E onwards

  • Consumer earnings in FY22E to be driven by local H&PC business

  • We maintain our target price of LKR 140.00/share and BUY rating

Asia Securities
14 June 2021
Published byAsia Securities


Tellimer | Start Following

Start following your markets today

Follow your key analysts, markets and more so they appear here in your Watchlist - allowing you to keep an eye on the latest updates.